{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:48:03Z","timestamp":1793944083157,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"JPND\/JPco-fuND 2","award":["825664"],"award-info":[{"award-number":["825664"]}]},{"name":"NHRMC Emerging Leadership","award":["GNT2010064"],"award-info":[{"award-number":["GNT2010064"]}]},{"name":"NHMRC Leadership Fellowship","award":["GNT2008020"],"award-info":[{"award-number":["GNT2008020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22667-y","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:07:30Z","timestamp":1762434450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Glial and neuronal cell-free DNA in plasma of sporadic bvFTD and late onset primary psychiatric disease patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Zac","family":"Chatterton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterre C. M.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Matis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fenoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishana","family":"Rue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Landin-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Southwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Arighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Diehl-Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande A. L.","family":"Pijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"22667_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4088\/JCP.10m06382oli","volume":"72","author":"JD Woolley","year":"2011","unstructured":"Woolley, J. D., Khan, B. K., Murthy, N. K., Miller, B. L. & Rankin, K. P. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J. Clin. Psychiatry. 72, 126\u2013133. https:\/\/doi.org\/10.4088\/JCP.10m06382oli (2011).","journal-title":"J. Clin. Psychiatry"},{"key":"22667_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3233\/jad-170608","volume":"60","author":"WA Krudop","year":"2017","unstructured":"Krudop, W. A. et al. The pitfall of behavioral variant frontotemporal dementia mimics despite multidisciplinary application of the FTDC criteria. J. Alzheimers Dis. 60, 959\u2013975. https:\/\/doi.org\/10.3233\/jad-170608 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"22667_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1176\/jnp.14.4.424","volume":"14","author":"MF Mendez","year":"2002","unstructured":"Mendez, M. F. & Perryman, K. M. Neuropsychiatric features of frontotemporal dementia. J. Neuropsychiatry Clin. Neurosci. 14, 424\u2013429. https:\/\/doi.org\/10.1176\/jnp.14.4.424 (2002).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"22667_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jagp.2023.02.006","volume":"31","author":"SCM de Boer","year":"2023","unstructured":"de Boer, S. C. M. et al. Diagnostic instability over time in the Late-Onset frontal lobe syndrome: when can we say it\u2019s FTD? Am. J. Geriatric Psychiatry. 31, 679\u2013690. https:\/\/doi.org\/10.1016\/j.jagp.2023.02.006 (2023).","journal-title":"Am. J. Geriatric Psychiatry"},{"key":"22667_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-020-00753-9","volume":"13","author":"M Leroy","year":"2021","unstructured":"Leroy, M. et al. Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network. Alzheimers Res. Ther. 13, 19. https:\/\/doi.org\/10.1186\/s13195-020-00753-9 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"22667_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.neuropsych.20100266","volume":"34","author":"P Tsoukra","year":"2022","unstructured":"Tsoukra, P. et al. The diagnostic challenge of Young-Onset dementia syndromes and primary psychiatric diseases: results from a retrospective 20-Year Cross-Sectional study. J. Neuropsychiatry Clin. Neurosci. 34, 44\u201352. https:\/\/doi.org\/10.1176\/appi.neuropsych.20100266 (2022).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"22667_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1212\/WNL.0b013e3181bf997a","volume":"73","author":"J Rohrer","year":"2009","unstructured":"Rohrer, J. et al. The heritability and genetics of frontotemporal Lobar degeneration. Neurology 73, 1451\u20131456 (2009).","journal-title":"Neurology"},{"key":"22667_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(19)30394-1","volume":"19","author":"KM Moore","year":"2020","unstructured":"Moore, K. M. et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 19, 145\u2013156. https:\/\/doi.org\/10.1016\/S1474-4422(19)30394-1 (2020).","journal-title":"Lancet Neurol."},{"key":"22667_CR9","doi-asserted-by":"publisher","first-page":"148e149","DOI":"10.1016\/j.neurobiolaging.2020.07.014","volume":"97","author":"MO Mol","year":"2021","unstructured":"Mol, M. O. et al. Underlying genetic variation in Familial frontotemporal dementia: sequencing of 198 patients. Neurobiol. Aging. 97, 148e149. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.07.014 (2021). 148.e116.","journal-title":"Neurobiol. Aging"},{"key":"22667_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/alz.12046","volume":"16","author":"HW Heuer","year":"2020","unstructured":"Heuer, H. W. et al. Comparison of sporadic and Familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Alzheimers Dement. 16, 60\u201370. https:\/\/doi.org\/10.1002\/alz.12046 (2020).","journal-title":"Alzheimers Dement."},{"key":"22667_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/alz.12046","volume":"16","author":"HW Heuer","year":"2020","unstructured":"Heuer, H. W. et al. Comparison of sporadic and Familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc. 16, 60\u201370. https:\/\/doi.org\/10.1002\/alz.12046 (2020).","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"22667_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/psyg.12898","volume":"23","author":"JLP Fieldhouse","year":"2023","unstructured":"Fieldhouse, J. L. P. et al. A caregiver\u2019s perspective on clinically relevant symptoms in behavioural variant frontotemporal dementia: tools for disease management and trial design. Psychogeriatrics 23, 11\u201322. https:\/\/doi.org\/10.1111\/psyg.12898 (2023).","journal-title":"Psychogeriatrics"},{"key":"22667_CR13","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/brain\/awaa018","volume":"143","author":"S Ducharme","year":"2020","unstructured":"Ducharme, S. et al. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain 143, 1632\u20131650. https:\/\/doi.org\/10.1093\/brain\/awaa018 (2020).","journal-title":"Brain"},{"key":"22667_CR14","unstructured":"de Boer, S. A. O. et al. Serum Neurofilament Light Is Superior To Glial Fibrillary Acidic Protein To Distinguish Sporadic Frontotemporal Dementia from late-onset Primary Psychiatric Disorders: a retrospective DIPPA-FTD study."},{"key":"22667_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1086\/301800","volume":"62","author":"YM Lo","year":"1998","unstructured":"Lo, Y. M. et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62, 768\u2013775. https:\/\/doi.org\/10.1086\/301800 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"22667_CR16","doi-asserted-by":"publisher","unstructured":"Salkeni, M. A. et al. Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients. Journal of neuro-oncology 115, 27\u201335 (2013). https:\/\/doi.org\/10.1007\/s11060-013-1209-0","DOI":"10.1007\/s11060-013-1209-0"},{"key":"22667_CR17","doi-asserted-by":"publisher","unstructured":"Chatterton, Z. et al. Bisulfite amplicon sequencing can detect glia and neuron Cell-Free DNA in blood plasma. Front. Mol. Neurosci. 14 https:\/\/doi.org\/10.3389\/fnmol.2021.672614 (2021).","DOI":"10.3389\/fnmol.2021.672614"},{"key":"22667_CR18","doi-asserted-by":"publisher","unstructured":"Veltri, A. et al. Plasma Brain-Derived Neurotrophic Factor (BDNF) Levels and BDNF Promoters\u2019 DNA Methylation in Workers Exposed to Occupational Stress and Suffering from Psychiatric Disorders. Brain Sci. 14 https:\/\/doi.org\/10.3390\/brainsci14111106 (2024).","DOI":"10.3390\/brainsci14111106"},{"key":"22667_CR19","doi-asserted-by":"publisher","unstructured":"Melamud, M. M., Buneva, V. N. & Ermakov, E. A. Circulating Cell-Free DNA levels in psychiatric diseases: A systematic review and Meta-Analysis. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24043402 (2023).","DOI":"10.3390\/ijms24043402"},{"key":"22667_CR20","doi-asserted-by":"publisher","unstructured":"Lubotzky, A. et al. Elevated brain-derived cell-free DNA among patients with first psychotic episode - a proof-of-concept study. Elife 11 https:\/\/doi.org\/10.7554\/eLife.76391 (2022).","DOI":"10.7554\/eLife.76391"},{"key":"22667_CR21","doi-asserted-by":"publisher","first-page":"e12285","DOI":"10.1002\/dad2.12285","volume":"14","author":"EH Thijssen","year":"2022","unstructured":"Thijssen, E. H. et al. Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia. Alzheimers Dement. (Amst). 14, e12285. https:\/\/doi.org\/10.1002\/dad2.12285 (2022).","journal-title":"Alzheimers Dement. (Amst)"},{"key":"22667_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jnc.13399","volume":"136","author":"A Ishiki","year":"2016","unstructured":"Ishiki, A. et al. Glial fibrillar acidic protein in the cerebrospinal fluid of alzheimer\u2019s disease, dementia with lewy bodies, and frontotemporal Lobar degeneration. J. Neurochem. 136, 258\u2013261 (2016).","journal-title":"J. Neurochem."},{"key":"22667_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.dadm.2017.01.009","volume":"7","author":"EG Vijverberg","year":"2017","unstructured":"Vijverberg, E. G. et al. Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders. Alzheimers Dement. (Amst). 7, 99\u2013106. https:\/\/doi.org\/10.1016\/j.dadm.2017.01.009 (2017).","journal-title":"Alzheimers Dement. (Amst)"},{"key":"22667_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00415-019-09567-8","volume":"267","author":"K Katisko","year":"2020","unstructured":"Katisko, K. et al. Serum neurofilament light chain is a discriminative biomarker between frontotemporal Lobar degeneration and primary psychiatric disorders. J. Neurol. 267, 162\u2013167. https:\/\/doi.org\/10.1007\/s00415-019-09567-8 (2020).","journal-title":"J. Neurol."},{"key":"22667_CR25","doi-asserted-by":"publisher","first-page":"120439","DOI":"10.1016\/j.jns.2022.120439","volume":"442","author":"D Eratne","year":"2022","unstructured":"Eratne, D. et al. Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors. J. Neurol. Sci. 442, 120439. https:\/\/doi.org\/10.1016\/j.jns.2022.120439 (2022).","journal-title":"J. Neurol. Sci."},{"key":"22667_CR26","doi-asserted-by":"publisher","unstructured":"Eratne, D. et al. Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders. Aust N Z. J. Psychiatry. 48674231187312 https:\/\/doi.org\/10.1177\/00048674231187312 (2023).","DOI":"10.1177\/00048674231187312"},{"key":"22667_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpsychires.2019.03.019","volume":"113","author":"MHDR Al Shweiki","year":"2019","unstructured":"Al Shweiki, M. H. D. R. et al. Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia. J. Psychiatr. Res. 113, 137\u2013140. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.03.019 (2019).","journal-title":"J. Psychiatr. Res."},{"key":"22667_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/jnnp-2021-326487","volume":"92","author":"K Katisko","year":"2021","unstructured":"Katisko, K. et al. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance. J. Neurol. Neurosurg. Psychiatry. 92, 1305\u20131312. https:\/\/doi.org\/10.1136\/jnnp-2021-326487 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"22667_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40035-021-00275-w","volume":"10","author":"N Zhu","year":"2021","unstructured":"Zhu, N. et al. Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia. Transl Neurodegener. 10, 50. https:\/\/doi.org\/10.1186\/s40035-021-00275-w (2021).","journal-title":"Transl Neurodegener"},{"key":"22667_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","volume":"93","author":"L Chouliaras","year":"2022","unstructured":"Chouliaras, L. et al. Differential levels of plasma biomarkers of neurodegeneration in lewy body dementia, alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry. 93, 651\u2013658. https:\/\/doi.org\/10.1136\/jnnp-2021-327788 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"22667_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","volume":"14","author":"S Baiardi","year":"2022","unstructured":"Baiardi, S. et al. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias. Alzheimers Res. Ther. 14, 153. https:\/\/doi.org\/10.1186\/s13195-022-01093-6 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"22667_CR32","doi-asserted-by":"publisher","first-page":"e860","DOI":"10.1212\/WNL.0000000000201597","volume":"100","author":"J Sarto","year":"2023","unstructured":"Sarto, J. et al. Diagnostic performance and clinical applicability of Blood-Based biomarkers in a prospective memory clinic cohort. Neurology 100, e860\u2013e873. https:\/\/doi.org\/10.1212\/WNL.0000000000201597 (2023).","journal-title":"Neurology"},{"key":"22667_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13195-022-01091-8","volume":"14","author":"K Katisko","year":"2022","unstructured":"Katisko, K. et al. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype. Alzheimers Res. Ther. 14, 151. https:\/\/doi.org\/10.1186\/s13195-022-01091-8 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"22667_CR34","doi-asserted-by":"publisher","unstructured":"Bentivenga, G. M. et al. Diagnostic and prognostic value of plasma GFAP in sporadic Creutzfeldt-Jakob disease in the clinical setting of rapidly progressive dementia. Int. J. Mol. Sci. 25 https:\/\/doi.org\/10.3390\/ijms25105106 (2024).","DOI":"10.3390\/ijms25105106"},{"key":"22667_CR35","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/acn3.51234","volume":"7","author":"C Barro","year":"2020","unstructured":"Barro, C., Chitnis, T. & Weiner, H. L. Blood neurofilament light: a critical review of its application to neurologic disease. Ann. Clin. Transl Neurol. 7, 2508\u20132523. https:\/\/doi.org\/10.1002\/acn3.51234 (2020).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"22667_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","volume":"22","author":"X Wang","year":"2024","unstructured":"Wang, X., Shi, Z., Qiu, Y., Sun, D. & Zhou, H. Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK biobank. BMC Med. 22, 192. https:\/\/doi.org\/10.1186\/s12916-024-03418-8 (2024).","journal-title":"BMC Med."},{"key":"22667_CR37","doi-asserted-by":"publisher","first-page":"672614","DOI":"10.3389\/fnmol.2021.672614","volume":"14","author":"Z Chatterton","year":"2021","unstructured":"Chatterton, Z. et al. Bisulfite amplicon sequencing can detect glia and neuron Cell-Free DNA in blood plasma. Front. Mol. Neurosci. 14, 672614. https:\/\/doi.org\/10.3389\/fnmol.2021.672614 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"22667_CR38","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3233\/JAD-230829","volume":"97","author":"SCM de Boer","year":"2024","unstructured":"de Boer, S. C. M. et al. Rationale and design of the diagnostic and prognostic precision algorithm for behavioral variant frontotemporal dementia (DIPPA-FTD) study: A study aiming to distinguish early stage sporadic FTD from Late-Onset primary psychiatric disorders. J. Alzheimers Dis. 97, 963\u2013973. https:\/\/doi.org\/10.3233\/JAD-230829 (2024).","journal-title":"J. Alzheimers Dis."},{"key":"22667_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.mcp.2016.06.001","volume":"30","author":"EM Cleary","year":"2016","unstructured":"Cleary, E. M. et al. Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions. Mol. Cell. Probes. 30, 218\u2013224. https:\/\/doi.org\/10.1016\/j.mcp.2016.06.001 (2016).","journal-title":"Mol. Cell. Probes"},{"key":"22667_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1212\/WNL.0b013e31820a0d13","volume":"76","author":"JS Goldman","year":"2011","unstructured":"Goldman, J. S. et al. An algorithm for genetic testing of frontotemporal Lobar degeneration. Neurology 76, 475\u2013483. https:\/\/doi.org\/10.1212\/WNL.0b013e31820a0d13 (2011).","journal-title":"Neurology"},{"key":"22667_CR41","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1001\/jamaneurol.2013.3956","volume":"70","author":"EM Wood","year":"2013","unstructured":"Wood, E. M. et al. Development and validation of pedigree classification criteria for frontotemporal Lobar degeneration. JAMA Neurol. 70, 1411\u20131417. https:\/\/doi.org\/10.1001\/jamaneurol.2013.3956 (2013).","journal-title":"JAMA Neurol."},{"key":"22667_CR42","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & Kaller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048. https:\/\/doi.org\/10.1093\/bioinformatics\/btw354 (2016).","journal-title":"Bioinformatics"},{"key":"22667_CR43","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27, 1571\u20131572. https:\/\/doi.org\/10.1093\/bioinformatics\/btr167 (2011).","journal-title":"Bioinformatics"},{"key":"22667_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527. https:\/\/doi.org\/10.1038\/nbt.3519 (2016).","journal-title":"Nat. Biotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22667-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:07:33Z","timestamp":1762434453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22667-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22667"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22667-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. The retrospective DIPPA-FTD study was approved by the institutional review boards or ethics committees at each participating center, including the Alzheimer Center Amsterdam (Amsterdam UMC), Brain and Mind Centre at the University of Sydney, Douglas Mental Health University Institute at McGill University, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico (Milan), and the Technical University of Munich. Informed consent was obtained from all participants and\/or their legal guardians prior to inclusion in the DIPPA-FTD study and use of biological samples. The study conformed to the principles of the Declaration of Helsinki and all local regulations for research involving human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"38844"}}